SCHEMBL5330070

SCHEMBL5330070

COC1=C(C)C(=O)C(NC(C)=O)=CC1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.47
S100A4 P26447 1/20 0.47
IDO1 P14902 6/20 0.41
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
HKDC1 Q2TB90 2/20 0.39
HSP90AA1 P07900 2/20 0.37
HSP90AB1 P08238 2/20 0.37
KDM4E B2RXH2 2/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 1/20 0.36
APEX1 P27695 1/20 0.36
ALDH1A1 P00352 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MAPT P10636 1/20 0.35
MAPK1 P28482 1/20 0.35
MCL1 Q07820 1/20 0.35
ATM Q13315 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14386783 0.81 TDP1 (0.49) TDP1S100A4IDO1MEN1NPC1
SCHEMBL11241564 0.71 TDP1 (0.42) TDP1S100A4IDO1MEN1NPC1
SCHEMBL7898541 0.71 HSP90AA1 (0.45) TDP1S100A4IDO1MEN1NPC1
SCHEMBL20098769 0.71 CDC25A (0.40) TDP1IDO1CYP1A2CYP2C9APEX1
SCHEMBL17123733 0.71 MALT1 (0.44) TDP1IDO1RAB9AHKDC1KDM4E
SCHEMBL8653625 0.70 RAB9A (0.72) TDP1S100A4IDO1MEN1NPC1
SCHEMBL5328866 0.70 TDP1 (0.42) TDP1S100A4IDO1MEN1NPC1
SCHEMBL5328420 0.69 TDP1 (0.41) TDP1S100A4IDO1MEN1NPC1
SCHEMBL28654605 0.68 TDP1 (0.46) TDP1S100A4IDO1MEN1NPC1
SCHEMBL5329038 0.68 TDP1 (0.40) TDP1S100A4IDO1MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007134328-A2 GELDANAMYCINS AND THEIR QUINONE MOIETIES INHIBIT CANCER BY ACTING ON MITOCHONDRIAL VOLTAGE-DEPENDENT ANION CHANNEL (VDAC) PROTEIN VAN ANDEL RESEARCH INSTITUTE (US) 2007-11-22 WO claimed
WO-2007134328-A2 GELDANAMYCINS AND THEIR QUINONE MOIETIES INHIBIT CANCER BY ACTING ON MITOCHONDRIAL VOLTAGE-DEPENDENT ANION CHANNEL (VDAC) PROTEIN VAN ANDEL RESEARCH INSTITUTE (US) 2007-11-22 WO disclosed